Two-year patient-reported outcomes following treatment of uveal melanoma – (Eye Journal AOP)
Two-year patient-reported outcomes following treatment of uveal melanoma Eye advance online publication, September 2 2016. doi:10.1038/eye.2016.188 Authors: L Hope-Stone, S L Brown, H Heimann, B Damato & P Salmon
Clinical characteristics and prognostic factors of scleral rupture due to blunt ocular trauma – (Eye Journal AOP)
Clinical characteristics and prognostic factors of scleral rupture due to blunt ocular trauma Eye advance online publication, September 2 2016. doi:10.1038/eye.2016.194 Authors: O E Yucel, S Demir, L Niyaz, O Sayin, A Gul & N Ariturk
Real world outcomes of ocriplasmin use by members of the British and Eire Association of Vitreoretinal Surgeons – (Eye Journal AOP)
Real world outcomes of ocriplasmin use by members of the British and Eire Association of Vitreoretinal Surgeons Eye advance online publication, September 2 2016. doi:10.1038/eye.2016.195 Authors: R J Haynes, D Yorston, D A H Laidlaw, J Keller & D H W Steel
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option – (Eye Journal AOP)
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option Eye advance online publication, August 26 2016. doi:10.1038/eye.2016.174 Authors: M Ashraf, A Souka, R Adelman & S H Forster
TGFβ induces BIGH3 expression and human retinal pericyte apoptosis: a novel pathway of diabetic retinopathy – (Eye Journal AOP)
TGFβ induces BIGH3 expression and human retinal pericyte apoptosis: a novel pathway of diabetic retinopathy Eye advance online publication, August 26 2016. doi:10.1038/eye.2016.179 Authors: B S Betts-Obregon, A A Mondragon, A S Mendiola, R G LeBaron, R Asmis, T Zou, F Gonzalez-Fernandez & A T Tsin